Hyperbilirubinemia, Neonatal Clinical Trial
Official title:
Effect of Early Limited Formula on Total Serum Bilirubin Among Newborns With Hyperbilirubinemia
Verified date | November 2018 |
Source | University of California, San Francisco |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The investigators propose to conduct an exploratory pilot study, enrolling 30 exclusively breastfeeding newborns 36-96 hours of age, whose Total Serum Bilirubin (TSB) is within 0.1-3 mg/dl of the American Academy of Pediatrics (AAP)-recommended treatment thresholds for Phototherapy (PT). These newborns will be randomly assigned to receive either 10 cc extensively hydrolyzed formula following each breastfeeding using cup, spoon or syringe, or to continue exclusive breastfeeding. Infants will be followed at 1, 2, 3 and 6 months to assess breastfeeding duration and use of formula and complementary foods. Our hypothesis is that limited, small amounts of formula administered without a bottle immediately following breastfeeding might reduce the incidence of severe hyperbilirubinemia among newborns at increased risk of TSB exceeding AAP-recommended thresholds for beginning phototherapy.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | June 2016 |
Est. primary completion date | July 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A to 96 Hours |
Eligibility |
Inclusion Criteria: - Healthy infants = 35 weeks - Neonates 36-96 hours old - Exclusively breastfeeding - TSB 0.1-3 mg/dl below AAP-recommended PT threshold - TSB < 6 hours ago - Mothers English-speaking or Spanish-speaking Exclusion Criteria: - Infants who have already received formula - Infants who have received or are receiving Level II or Level III - Infants who have already lost = 10% birth weight - Infants with Glucose-6-phosphate dehydrogenase deficiency, positive direct antigen testing, cephalohematoma or other extensive bruising |
Country | Name | City | State |
---|---|---|---|
United States | University of California, San Francisco Medical Center | San Francisco | California |
Lead Sponsor | Collaborator |
---|---|
University of California, San Francisco |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | TSB meeting or exceeding AAP-recommended phototherapy treatment threshold. | The investigators will compare measured TSB to AAP guideline recommendations for phototherapy treatment and confirming with Bili Tool, an automated program designed for this purpose. | Up to two weeks after birth | |
Secondary | Receipt of phototherapy and hospital readmission, exclusive and partial breastfeeding at 1 week, 1 month, 2 months, and 3 months; breastfeeding self-efficacy | The investigators will ask mothers whether the infant received any breast milk in the last 24 hours. For infants whose mothers state they have received breast milk in the last 24 hours, the investigators will ask mothers whether the infant received anything other than breast milk in the last 24 hours. The investigators will ask mothers whether the infant received anything other than breast milk since the prior assessment. The investigators will query subjects using the Breastfeeding Self Efficacy Scale, short form, at enrollment, 1week and at 1 month. | Up to three months after birth |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04868019 -
Role of Fenofibrate in Indirect Neonatal Hyperbilirubinemia: a Randomized Control Trial
|
N/A | |
Completed |
NCT00114543 -
Trial of Aggressive Versus Conservative Phototherapy in Infants <1,000 Grams Birth Weight
|
Phase 3 | |
Completed |
NCT02000830 -
Follow up Study of Patients Having Participated in Clinical Trial 64,185-204
|
||
Completed |
NCT01887327 -
Stannsoporfin With Light Therapy for Newborn Babies With Jaundice
|
Phase 2 | |
Completed |
NCT05356273 -
The Effect of Massage on the Bilirubin Level in Term Infants Receiving Phototherapy
|
N/A | |
Suspended |
NCT03741803 -
Relationship Between Delayed Cord Clamping at Birth and Neonatal Bilirubin Levels in Parturients With a Prior Child Requiring Therapy for Neonatal Jaundice
|
N/A | |
Recruiting |
NCT03876678 -
The Efficacy of Oral Probiotics on Neonatal Hyperbilirubinemia
|
N/A | |
Not yet recruiting |
NCT05365984 -
Intelligent Follow-up of Neonatal Jaundice Based on Early Indicators and Internet Communications
|
N/A | |
Recruiting |
NCT04251286 -
Screening and Follow-up Study of Neonatal Jaundice Based on Mobile Network
|
||
Completed |
NCT03723005 -
A Light Emitting Diode (LED) Mattress for Phototherapy of Jaundiced Newborns
|
||
Recruiting |
NCT06087874 -
Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal Jaundice
|
Phase 2 | |
Completed |
NCT03624335 -
Influence of Umbilical Cord Clamping Time in the Newborn
|
N/A | |
Recruiting |
NCT06324799 -
The Effect of Position Change Frequency on Hyperbilirubinemia
|
N/A | |
Recruiting |
NCT06209489 -
White Cover and Massage Impact on Bilirubin Levels and Phototherapy Duration in Newborns
|
N/A | |
Completed |
NCT03824990 -
Multi-center Clinical Study on Neonatal Hyperbilirubinemia
|
N/A | |
Completed |
NCT01169740 -
Transcutaneous Measurement of Jaundice in the Newborn
|
N/A | |
Recruiting |
NCT06238349 -
Hyperbilirubinemia in Full-term Neonates
|
Phase 4 | |
Completed |
NCT03007563 -
Evaluation of a Smartphone Based Optical Diagnostic Tool for Neonatal Jaundice
|
N/A | |
Completed |
NCT01763632 -
Development of TcB Nomogram to Identify Neonatal Hyperbilirubinemia in Term and Late-preterm Infants
|
N/A | |
Completed |
NCT01762189 -
The Incidence and Risk Factors of Neonatal Hyperbilirubinemia in Term and Late-preterm Chinese Infants
|
N/A |